-
1
المؤلفون: Locati, Laura D, Licitra, Lisa, Agate, Laura, Sai Hong I., Ou, Boucher, Andree, Jarzab, Barbara, Qin, Shukui, Kane, Madeleine A., Wirth, Lori J., Chen, Connie, Kim, Sinil, Ingrosso, Antonella, Pithavala, Yazdi K., Bycott, Paul, Cohen, Ezra E. W.
المصدر: Cancer. 120(17)
مصطلحات موضوعية: Adult, Diarrhea, Male, Cancer Research, radioactive iodine-refractory, Indazoles, Lung Neoplasms, Axitinib, Papillary, Antineoplastic Agents, Kaplan-Meier Estimate, Disease-Free Survival, tyrosine kinase inhibitor, thyroid cancer, 80 and over, axitinib, MD Anderson Symptom Inventory, metastatic disease, pharmacodynamic, pharmacokinetic, quality of life, Aged, Aged, 80 and over, Carcinoma, Papillary, Female, Humans, Imidazoles, Middle Aged, Quality of Life, Thyroid Neoplasms, Treatment Outcome, Oncology, Carcinoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::35dd9aead4f5540d0b2ec3a2035a833fTest
https://pubmed.ncbi.nlm.nih.gov/24844950Test -
2
المؤلفون: Garrett, May, Poland, Bill, Brennan, Meghan, Hee, Brian, Pithavala, Yazdi K, Amantea, Michael A
مصطلحات موضوعية: Adult, Male, Indazoles, Axitinib, Clinical Trials, Phase I as Topic, Genotype, Body Weight, Imidazoles, Angiogenesis Inhibitors, Middle Aged, Models, Biological, Healthy Volunteers, Cytochrome P-450 CYP2C19, Young Adult, Phenotype, Nonlinear Dynamics, Pharmacogenetics, Humans, Pharmacokinetics, Drug Dosage Calculations, Female, Aryl Hydrocarbon Hydroxylases, Glucuronosyltransferase, Protein Kinase Inhibitors, Biotransformation
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::dda064ca6c77fa34b9eb1cb00ad02876Test
https://europepmc.org/articles/PMC3952722Test/ -
3دورية أكاديمية
المؤلفون: Rini, Brian I1 rinib2@ccf.org, Melichar, Bohuslav2, Ueda, Takeshi3, Grünwald, Viktor4, Fishman, Mayer N5, Arranz, José A6, Bair, Angel H7, Pithavala, Yazdi K7, Andrews, Glen I7, Pavlov, Dmitri8, Kim, Sinil7, Jonasch, Eric9
المصدر: Lancet Oncology. Nov2013, Vol. 14 Issue 12, p1233-1242. 10p.
مصطلحات موضوعية: *INDAZOLES, *RENAL cell carcinoma, *PHARMACOKINETICS, *HEALTH outcome assessment, *BLOOD pressure, *PLACEBOS, *PATIENTS